The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Multiple Electrolytes pH 5.5
sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride · SODIUM CHLORIDE 526 mg/100mL; SODIUM GLUCONATE 502 mg/100mL; SODIUM ACETATE 368 mg/100mL; POTASSIUM CHLORIDE 37 mg/100mL; MAGNESIUM CHLORIDE 30 mg/100mL · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC
NDC 65219-0387-05 · 20 BAG in 1 CASE / 500 mL in 1 BAG · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 00338-0221-04) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.0170per unit
middle half $0.0170–$0.0172 · 1,161 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0170
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
21%of plans cover it
tier 4 · prior auth 2% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$254.40
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · api manufacture · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA215370
- TE code
- —
- Approval date
- Jun 29, 2022
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of sodium chloride, sodium gluconate, sodium acetate, potassium chloride and magnesium chloride (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Baxter Healthcare Corporation | SODIUM CHLORIDE 526 mg/100mL; SODIUM GLUCONATE 502 mg/100mL; SODIUM ACETATE 368 mg/100mL; POTASSIUM CHLORIDE 37 mg/100mL; MAGNESIUM CHLORIDE 30 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | SODIUM CHLORIDE 526 mg/100mL; SODIUM GLUCONATE 502 mg/100mL; SODIUM ACETATE 368 mg/100mL; POTASSIUM CHLORIDE 37 mg/100mL; MAGNESIUM CHLORIDE 30 mg/100mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | SODIUM CHLORIDE 30 mg/100mL; SODIUM GLUCONATE 37 mg/100mL; SODIUM ACETATE 368 mg/100mL; POTASSIUM CHLORIDE 526 mg/100mL; MAGNESIUM CHLORIDE 502 mg/100mL | Jul 22, 2026 | Aug 20, 2026 |
| Baxter Healthcare Corporation | SODIUM CHLORIDE 30 mg/100mL; SODIUM GLUCONATE 37 mg/100mL; SODIUM ACETATE 368 mg/100mL; POTASSIUM CHLORIDE 526 mg/100mL; MAGNESIUM CHLORIDE 502 mg/100mL | Jul 22, 2026 | Aug 19, 2026 |
| Fresenius Kabi USA, LLC | MAGNESIUM CHLORIDE 30 mg/100mL; POTASSIUM CHLORIDE 37 mg/100mL; SODIUM ACETATE 368 mg/100mL; SODIUM CHLORIDE 526 mg/100mL; SODIUM GLUCONATE 502 mg/100mL | Jul 15, 2026 | Jul 19, 2026 |
| Baxter Healthcare Corporation | MAGNESIUM CHLORIDE 30 mg/100mL; POTASSIUM CHLORIDE 37 mg/100mL; SODIUM ACETATE 368 mg/100mL; SODIUM CHLORIDE 526 mg/100mL; SODIUM GLUCONATE 502 mg/100mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Multiple Electrolytes pH 5.5 — NDC 65219-0387-05," retrieved September 3, 2026, https://drugdashboards.com/drug/65219038705.
Free to cite with attribution — see how the data is put together.